Evidence map›Paper›PMID 36915115›Full record

ArticleThe journal of headache and pain2023

Cross-sectional, hospital-based analysis of headache types using ICHD-3 criteria in the Middle East, Asia, and Africa: the Head-MENAA study.

H Genc, B Baykan, H Bolay, D Uluduz, I Unal-Cevik, N Kissani, O Luvsannorov, M Togha, A A Ozdemir, A Ozge and 1 more

Full text readMulticenter Study
In one paragraph

Article in The journal of headache and pain, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Awareness of medication-overuse headache in Hail, Saudi Arabia.Journal of family medicine and primary care · 2026
    Article
  6. Article
  7. Machine learning-based migraine analysis using retinal vessel diameters from optical coherence tomography: an alternative approach.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2025
    Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

H GencVan Training and Research Hospital, University of Health Sciences, Van, Turkey. hgenc8987@gmail.com.
B BaykanIstanbul Faculty of Medicine, EMAR Medical Center, Istanbul University, Istanbul, Turkey.
H BolayFaculty of Medicine, Department of Neurology and Algology, Gazi University, NOROM, Ankara, Turkey.
D UluduzMedical Faculty, Department of Neurology, Istanbul University-Cerrahpaşa, Istanbul, Turkey.
I Unal-CevikFaculty of Medicine, Department of Neurology, Hacettepe University, Ankara, Turkey.
N KissaniNeuroscience Research Laboratory in Marrakesh Medical School, Cadi Ayyad University, Marrakech, Morocco.
O LuvsannorovDepartment of Neurology, Mongolian National University of Medical Sciences, Ulaanbaatar, Mongolia.
M ToghaDepartment of Neurology, Tehran University of Medical Sciences, Tehran, Iran.
A A OzdemirDepartment of Biostatistics and Medical Informatics, University of Mersin, Mersin, Turkey.
A OzgeFaculty of Medicine, Department of Neurology, Mersin University, Mersin, Turkey.
Head-MENAA study group

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundHeadaches are frequent neurological disorders that are yet to be unveiled and treated comprehensively worldwide. Bearing in mind that the distribution of headache subtypes in neurology clinics (NC) is essential for planning appropriate diagnostic and therapeutic approaches, the primary goals of this multi-centric study are to carry out inter-regional comparisons by using current diagnostic criteria with evaluations of neurologists to delineate headache burden.

methodsA cross-sectional study between April 1 and May 16, 2022 was conducted with the participation of 13 countries from the Middle East, Asia, and Africa. Patients were included in the study on a specific day each week during five consecutive weeks. All volunteers over the age of 18 and whose primary cause for admission was headache were examined. The patients admitted to NC or referred from emergency services/other services were evaluated by neurologists by means of the International Classification of Headache Disorders (ICHD-3) criteria.

resultsAmong the 13,794 patients encountered in NC, headache was the primary complaint in 30.04%. The headache patients' mean age was 42.85 ± 14.89 (18-95 years), and 74.3% were female. According to the ICHD-3 criteria, 86.7% of the main group had primary headache disorders, 33.5% had secondary headaches, 4% had painful cranial neuropathies along with other facial and headaches, and 5.2% had headaches included in the appendix part showing some overlapping conditions. While the most common primary headache was migraine without aura (36.8%), the most common secondary headache was medication-overuse headache (MOH) (9.8%). Headaches attributed to COVID-19, its secondary complications, or vaccines continue to occur at rates of 1.2%-3.5% in current neurology practice. Pain severity was significantly lower in Ivory Coast and Sudan than in Türkiye, Turkish Republic of Northern Cyprus, Iran, Egypt, Senegal, Tatarstan, and Azerbaijan (p < 0.001).

conclusionsThe study showed that migraine is still the most common motive for admissions to NC in different regions. Furthermore, MOH, an avoidable disorder, is the most common secondary headache type and appears to be a significant problem in all regions. Remarkably, pain perception differs between regions, and pain intensity is lower in Africa than in other regions.

Indexed as

COVID-19Headache DisordersHeadache Disorders, SecondaryMigraine DisordersAdultAfricaAsiaCross-Sectional StudiesFemaleHeadacheHospitalsHumansMaleMiddle AgedMiddle EastGeographic regionsHeadache frequencyICHD-3MigraineMOHNeurology clinicsPain perceptionThe Head-MENAA study

Identifiers

PMID36915115
PMCPMC10010217

What OpenQuestion holds

Textfull text, public
LicenceCC BY
measurements read169
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.